• Oral treatment of rabbits with bromovinyldeoxyuridine ([E]-5-[2-bromovinyl]2′-deoxyuridine) at 10 or 100 mg/kg/day for four days significantly reduced the severity of herpes simplex iritis. This effect was not potentiated by the concomitant subconjunctival injection of sustained-action betamethasone. A significant reduction in the severity of herpetic iritis was also observed on topical application of bromovinyldeoxyuridine, and, in this regard, 0.5% bromovinyldeoxyuridine eyedrops proved significantly more efficacious than 1% trifluridine eyedrops.
Maudgal PC, Uyttebroeck W, De Clercq E, Missotten L. Oral and Topical Treatment of Experimental Herpes Simplex Iritis With Bromovinyldeoxyuridine. Arch Ophthalmol. 1982;100(8):1337–1340. doi:10.1001/archopht.1982.01030040315025
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.